Riskpilot← Back to searchSign inGet full accessCH Medical AB
ABActiveOrg 5568136542Movägen 13General medical practice activities · NACE 8621Est. 20101 employees
Revenue 2024
SEK 1,5M
+47% vs 2023
EBITDA margin
-65.4%
-26% vs 2023
Equity ratio
82.7%
Financial strength
Net profit 2024
SEK 82K
+165% vs 2023
| Revenue | SEK 1,5M | +47% |
| EBITDA | SEK -1M | -26% |
| Net profit | SEK 82K | +165% |
| Total assets | SEK 23,5M | -4% |
| Equity | SEK 19,4M | +0% |
| Employees | 1 | — |
Legal name
CH Medical AB
Org number
5568136542
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 juli 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är sjukvård inom öron-näsa-hals området, inom allmän medicin och därmed förenlig verksamhet.
Address
Movägen 13
Phone
+4673388858
Email
entbob@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 763 | 9 437 | 1 047 | 1 046 | 1 536 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 163 | 2 204 | −3 084 | −798 | −1 004 |
| Depreciation & amort. | −207 | −204 | −219 | −137 | −121 |
| EBIT | 5 956 | 2 000 | −3 303 | −935 | −1 125 |
| Net financials | 25 | 209 | −287 | 498 | 1 173 |
| Profit before tax | 5 163 | 2 495 | 165 | 66 | 82 |
| Tax | −1 115 | −497 | −121 | −35 | −0 |
| Net profit | 4 048 | 1 998 | 44 | 31 | 82 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 28 432 | 28 727 | 25 724 | 24 573 | 23 490 |
| Equity | 18 913 | 20 061 | 19 305 | 19 336 | 19 418 |
| Long-term debt | 0 | 0 | 0 | 60 | 0 |
| Short-term debt | 1 181 | 614 | 1 964 | 1 225 | 155 |
| Total debt | 1 181 | 614 | 1 964 | 1 285 | 155 |
EBITDA margin
-65.4%
This company
15.8%
Market median
-514% vs market
20202024
Equity ratio
82.7%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2020 – 2024 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CH Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niclas Fredrik Antero Adersten | Audit | 0 companies |
| Robert Fon-Juei Chang | Board of Directors | 0 companies |
| Christine Chiu-Ping Huang | Board of Directors | 0 companies |
| Marcus You-Rong Chang | Deputy Board Member | 0 companies |